Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

NCT00258908 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
115
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi Pasteur, a Sanofi Company